Style | Citing Format |
---|---|
MLA | Seyedifar M, et al.. "Budget Impact Analysis of Temocillin Insurance Coverage for Urinary Tract Infections Caused by Esbl-Producing Pathogens in Iran." Medicine (United States), vol. 102, no. 35, 2023, pp. E34436-. |
APA | Seyedifar M, Sabouri M, Soodi O, Ghasemi H (2023). Budget Impact Analysis of Temocillin Insurance Coverage for Urinary Tract Infections Caused by Esbl-Producing Pathogens in Iran. Medicine (United States), 102(35), E34436-. |
Chicago | Seyedifar M, Sabouri M, Soodi O, Ghasemi H. "Budget Impact Analysis of Temocillin Insurance Coverage for Urinary Tract Infections Caused by Esbl-Producing Pathogens in Iran." Medicine (United States) 102, no. 35 (2023): E34436-. |
Harvard | Seyedifar M et al. (2023) 'Budget Impact Analysis of Temocillin Insurance Coverage for Urinary Tract Infections Caused by Esbl-Producing Pathogens in Iran', Medicine (United States), 102(35), pp. E34436-. |
Vancouver | Seyedifar M, Sabouri M, Soodi O, Ghasemi H. Budget Impact Analysis of Temocillin Insurance Coverage for Urinary Tract Infections Caused by Esbl-Producing Pathogens in Iran. Medicine (United States). 2023;102(35):E34436-. |
BibTex | @article{ author = {Seyedifar M and Sabouri M and Soodi O and Ghasemi H}, title = {Budget Impact Analysis of Temocillin Insurance Coverage for Urinary Tract Infections Caused by Esbl-Producing Pathogens in Iran}, journal = {Medicine (United States)}, volume = {102}, number = {35}, pages = {E34436-}, year = {2023} } |
RIS | TY - JOUR AU - Seyedifar M AU - Sabouri M AU - Soodi O AU - Ghasemi H TI - Budget Impact Analysis of Temocillin Insurance Coverage for Urinary Tract Infections Caused by Esbl-Producing Pathogens in Iran JO - Medicine (United States) VL - 102 IS - 35 SP - E34436 EP - PY - 2023 ER - |